Retraction Notice: The Role of CD276 in Promoting Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Through DNA Damage Repair and FAK-MAPK Pathway Activation - Quiz - MDSpire

Retraction Notice: The Role of CD276 in Promoting Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Through DNA Damage Repair and FAK-MAPK Pathway Activation

  • By

  • Zhi-yu Zhang

  • Jian-hao Xu

  • Jiang-lei Zhang

  • Yu-xin Lin

  • Jun Ou-Yang

  • January 12, 2026

  • 0 min

Share

Original Source(s)

Retraction Notice: The Role of CD276 in Promoting Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Through DNA Damage Repair and FAK-MAPK Pathway Activation

  • by Zhi-yu Zhang, Jian-hao Xu, Jiang-lei Zhang, Yu-xin Lin, Jun Ou-Yang

  • January 12, 2026

Related Content

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2